A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.
Michal HaranVita MirkinAndrei BraesterNurith HarpazOlga ShevetzMarina ShtreiterShulamit GreenbergOrly MordichOrna AmramInbal Binsky-EhrenreichAyelet MaromIdit ShacharYair HerishanuRosa RuchlemerAlain BerrebiLiora ValinskyMordechai ShtalridLev ShvidelPublished in: British journal of haematology (2017)